Premier (PINC) Q1 2025 earnings summary

Executive summary

• Fiscal Q1 2025 results slightly exceeded expectations for revenue and profitability, reaffirming full-year guidance.

• S2S Global direct sourcing business divested; Contigo Health divestiture ongoing, with results still included.

• Capital returned to shareholders via dividends and share repurchases under a $1 billion authorization, including a $400 million ASR and additional open market repurchases.

• $57 million non-operating gain from a derivative lawsuit settlement boosted net income.

• Leadership transition announced, with a new CFO to be introduced in the next quarter.

Financial highlights

• Total net revenue was $248.1 million, down 8% year-over-year.

• GAAP net income from continuing operations reached $72.9 million, up 75% year-over-year, aided by a $57 million legal settlement.

• Adjusted EBITDA was $62.4 million, down 33% year-over-year; adjusted net income $34.7 million, adjusted EPS $0.34.

• Free cash flow was $16.2 million, up from $12.3 million year-over-year.

• Cash and cash equivalents stood at $87 million at quarter end; no outstanding balance on $1 billion credit facility.

Outlook and guidance

• Fiscal 2025 guidance reaffirmed: total net revenue (ex-Contigo Health) $930M–$1.02B; adjusted EBITDA $235M–$255M; adjusted EPS $1.16–$1.28.

• Net administrative fees revenue projected at $495M–$525M; capex $90M–$100M; effective tax rate 25%–27%.

• Free cash flow expected at 45%–55% of adjusted EBITDA; cash income tax rate under 5%.

• Performance services and adjusted EBITDA expected to be more back half-weighted.

• Guidance excludes impact of future acquisitions or share repurchases beyond current ASR.